Anti-tumor effect of histone deacetylase inhibitors / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 754-757, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-693402
ABSTRACT
Histone deacetylase (HDAC) is a kind of protease,which plays an important role in the structural modification of chromosomes and the regulation of gene expression.Its excessive expression in cancer cells causes acetylation imbalance,which is closely related to the occurrence of tumor.The high efficiency and low toxicity of histone deacetylase inhibitor (HDACi) has been widely recognized as anti-tumor drug with the deepening of the study in epigenetics.It is expected to bring more breakthroughs in the treatment of tumor.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS